SMS PHARMACEUTICALS
|
SMS PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Equity - Authorised | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Equity - Issued | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Equity Paid Up | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 | ₹1.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹452 Cr | ₹462 Cr | ₹402 Cr | ₹340 Cr | ₹313 Cr |
Securities Premium | ₹70 Cr | ₹70 Cr | ₹70 Cr | ₹70 Cr | ₹70 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹288 Cr | ₹297 Cr | ₹248 Cr | ₹195 Cr | ₹179 Cr |
General Reserves | ₹93 Cr | ₹93 Cr | ₹83 Cr | ₹73 Cr | ₹63 Cr |
Other Reserves | ₹1.55 Cr | ₹1.55 Cr | ₹1.55 Cr | ₹1.55 Cr | ₹1.55 Cr |
Reserve excluding Revaluation Reserve | ₹452 Cr | ₹462 Cr | ₹402 Cr | ₹340 Cr | ₹313 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹461 Cr | ₹470 Cr | ₹411 Cr | ₹348 Cr | ₹322 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹120 Cr | ₹148 Cr | ₹146 Cr | ₹67 Cr | ₹61 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹67 Cr | ₹81 Cr | ₹81 Cr | ₹56 Cr | ₹57 Cr |
Term Loans - Institutions | ₹68 Cr | ₹81 Cr | ₹74 Cr | ₹34 Cr | - |
Other Secured | ₹-15 Cr | ₹-14 Cr | ₹-9.15 Cr | ₹-23 Cr | ₹4.18 Cr |
Unsecured Loans | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr | ₹1.20 Cr |
Deferred Tax Assets / Liabilities | ₹41 Cr | ₹40 Cr | ₹54 Cr | ₹40 Cr | ₹31 Cr |
Deferred Tax Assets | ₹2.87 Cr | ₹3.38 Cr | ₹5.37 Cr | ₹14 Cr | ₹16 Cr |
Deferred Tax Liability | ₹44 Cr | ₹43 Cr | ₹59 Cr | ₹53 Cr | ₹46 Cr |
Other Long Term Liabilities | ₹0.61 Cr | ₹2.11 Cr | ₹3.16 Cr | ₹4.78 Cr | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.41 Cr | ₹1.57 Cr | ₹1.84 Cr | ₹1.73 Cr | ₹1.52 Cr |
Total Non-Current Liabilities | ₹164 Cr | ₹193 Cr | ₹206 Cr | ₹114 Cr | ₹94 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹113 Cr | ₹73 Cr | ₹65 Cr | ₹44 Cr | ₹48 Cr |
Sundry Creditors | ₹113 Cr | ₹73 Cr | ₹65 Cr | ₹44 Cr | ₹48 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹47 Cr | ₹55 Cr | ₹58 Cr | ₹39 Cr | ₹23 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.15 Cr | ₹1.25 Cr | ₹4.66 Cr | ₹9.32 Cr | ₹8.60 Cr |
Interest Accrued But Not Due | - | - | - | ₹0.71 Cr | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹46 Cr | ₹53 Cr | ₹54 Cr | ₹29 Cr | ₹15 Cr |
Short Term Borrowings | ₹94 Cr | ₹68 Cr | ₹71 Cr | ₹61 Cr | ₹71 Cr |
Secured ST Loans repayable on Demands | ₹94 Cr | ₹68 Cr | ₹71 Cr | ₹61 Cr | ₹71 Cr |
Working Capital Loans- Sec | ₹94 Cr | ₹68 Cr | ₹71 Cr | ₹61 Cr | ₹71 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-94 Cr | ₹-68 Cr | ₹-71 Cr | ₹-61 Cr | ₹-71 Cr |
Short Term Provisions | ₹1.10 Cr | ₹16 Cr | ₹17 Cr | ₹9.72 Cr | ₹14 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.06 Cr | ₹15 Cr | ₹16 Cr | ₹9.00 Cr | ₹14 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹1.04 Cr | ₹1.02 Cr | ₹0.82 Cr | ₹0.72 Cr | ₹0.72 Cr |
Total Current Liabilities | ₹255 Cr | ₹211 Cr | ₹211 Cr | ₹154 Cr | ₹156 Cr |
Total Liabilities | ₹880 Cr | ₹875 Cr | ₹828 Cr | ₹617 Cr | ₹572 Cr |
ASSETS | |||||
Gross Block | ₹576 Cr | ₹570 Cr | ₹559 Cr | ₹361 Cr | ₹340 Cr |
Less: Accumulated Depreciation | ₹164 Cr | ₹132 Cr | ₹101 Cr | ₹80 Cr | ₹58 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹412 Cr | ₹438 Cr | ₹457 Cr | ₹280 Cr | ₹281 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹33 Cr | ₹11 Cr | ₹6.74 Cr | ₹42 Cr | ₹18 Cr |
Non Current Investments | ₹11 Cr | ₹22 Cr | ₹27 Cr | ₹26 Cr | ₹27 Cr |
Long Term Investment | ₹11 Cr | ₹22 Cr | ₹27 Cr | ₹26 Cr | ₹27 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹11 Cr | ₹22 Cr | ₹27 Cr | ₹26 Cr | ₹27 Cr |
Long Term Loans & Advances | ₹11 Cr | ₹9.32 Cr | ₹9.10 Cr | ₹38 Cr | ₹23 Cr |
Other Non Current Assets | ₹2.54 Cr | ₹2.61 Cr | ₹2.38 Cr | ₹2.25 Cr | ₹2.13 Cr |
Total Non-Current Assets | ₹469 Cr | ₹482 Cr | ₹503 Cr | ₹389 Cr | ₹351 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹223 Cr | ₹251 Cr | ₹138 Cr | ₹129 Cr | ₹136 Cr |
Raw Materials | ₹79 Cr | ₹70 Cr | ₹70 Cr | ₹34 Cr | ₹55 Cr |
Work-in Progress | ₹106 Cr | ₹119 Cr | ₹23 Cr | ₹44 Cr | ₹43 Cr |
Finished Goods | ₹32 Cr | ₹59 Cr | ₹25 Cr | ₹48 Cr | ₹34 Cr |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | - | - | - | - | - |
Other Inventory | ₹6.84 Cr | ₹3.23 Cr | ₹19 Cr | ₹3.37 Cr | ₹5.09 Cr |
Sundry Debtors | ₹148 Cr | ₹49 Cr | ₹106 Cr | ₹49 Cr | ₹26 Cr |
Debtors more than Six months | ₹1.69 Cr | ₹0.85 Cr | ₹2.10 Cr | - | - |
Debtors Others | ₹147 Cr | ₹48 Cr | ₹104 Cr | ₹49 Cr | ₹27 Cr |
Cash and Bank | ₹7.47 Cr | ₹47 Cr | ₹41 Cr | ₹9.65 Cr | ₹15 Cr |
Cash in hand | ₹0.08 Cr | ₹0.07 Cr | ₹0.09 Cr | ₹0.12 Cr | ₹0.05 Cr |
Balances at Bank | ₹7.39 Cr | ₹47 Cr | ₹40 Cr | ₹9.54 Cr | ₹15 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹6.00 Cr | ₹6.39 Cr | ₹19 Cr | ₹21 Cr | ₹27 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.38 Cr | ₹0.02 Cr | ₹0.11 Cr | ₹0.14 Cr | ₹0.15 Cr |
Prepaid Expenses | ₹4.93 Cr | ₹3.31 Cr | ₹2.22 Cr | ₹1.87 Cr | ₹1.05 Cr |
Other current_assets | ₹0.69 Cr | ₹3.07 Cr | ₹17 Cr | ₹19 Cr | ₹26 Cr |
Short Term Loans and Advances | ₹25 Cr | ₹39 Cr | ₹22 Cr | ₹19 Cr | ₹17 Cr |
Advances recoverable in cash or in kind | ₹3.52 Cr | ₹4.79 Cr | ₹3.18 Cr | ₹7.10 Cr | ₹3.15 Cr |
Advance income tax and TDS | ₹5.82 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr | ₹14 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹16 Cr | ₹15 Cr | - | - | - |
Total Current Assets | ₹411 Cr | ₹392 Cr | ₹325 Cr | ₹228 Cr | ₹221 Cr |
Net Current Assets (Including Current Investments) | ₹156 Cr | ₹181 Cr | ₹114 Cr | ₹74 Cr | ₹65 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹880 Cr | ₹875 Cr | ₹828 Cr | ₹617 Cr | ₹572 Cr |
Contingent Liabilities | ₹2.75 Cr | ₹8.12 Cr | ₹7.01 Cr | ₹1.74 Cr | ₹3.07 Cr |
Total Debt | ₹253 Cr | ₹260 Cr | ₹251 Cr | ₹152 Cr | ₹144 Cr |
Book Value | - | 55.56 | 48.50 | 41.14 | 38.03 |
Adjusted Book Value | 54.40 | 55.56 | 48.50 | 41.14 | 38.03 |
Compare Balance Sheet of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,746.1 Cr | 3.4% | 30.5% | 181.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,311.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹108,623.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,134.3 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹97,408.4 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹92,794.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | 3.4% |
30.5% |
181.2% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses